By 02 Posts SZD_Post 08-32
22 de April de 2019
BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats
Last by 02 Posts SZD_Post 08-32
26 de November de 2020
ANVISA published manuals related to prior consent of patent applications
The Brazilian FDA (ANVISA) published on November 19, 2020, four manuals regarding the analysis of prior consent of patent applications related to … ANVISA published manuals related to prior consent of patent applications
10 de July de 2019
BPTO publishes resolutions that will initiate the “Patent Backlog-fighting Project”
As part of the “Patent Backlog-fighting Project”, the Brazilian Patent and Trademark Office (BPTO) published Resolutions INPI Nos. 240/19 and 241/19 on … BPTO publishes resolutions that will initiate the “Patent Backlog-fighting Project”
22 de April de 2019
BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats
Amylin analogs are important adjunctive drugs in the treatment of diabetes mellitus. However, a dual therapy with insulin involves inconvenient multiple injections. … BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats